EP3317301
SAMSETTAR MEÐFERÐIR SEM FELAST Í AÐ GEFA MÓTEFNASAMEINDIR VIÐ LAG-3
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
28.7.2016EP published:
7.4.2021EP application number:
16757391.4
EP translation filed:
24.6.2021Grant published:
15.7.2021EPO information:
European Patent Register
Max expiry date:
27.7.2036Expiry date:
27.7.2026Next due date:
31.7.2026
Title:
COMBINATION THERAPIES COMPRISING ANTIBODY MOLECULES TO LAG-3
Timeline
Today
28.7.2016EP application
7.4.2021EP Publication
24.6.2021Translation submitted
15.7.2021Registration published
27.7.2026Expires
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056 Basel, CH
Name:
Immutep S.A.S.Address:
21 Rue Jean Rostand, 91893 Orsay Cedex, FR
Inventor
Name:
DRANOFF, GlennAddress:
Sudbury, MA 01776, US
Name:
TRIEBEL, FrédéricAddress:
78000 Versailles, FR
Name:
BRIGNONE, ChrystlleAddress:
92290 Chatenay-Malabry, FR
Name:
BLATTLER, Walter, A.Address:
Brookline, MA 02446-2768, US
Name:
MATARAZA, Jennifer, MarieAddress:
Cambridge, MA 02139, US
Name:
SABATOS-PEYTON, Catherine, AnneAddress:
Cambridge, MA 02139, US
Name:
CHANG, Hwai, WenAddress:
San Marcos, CA 92069, US
Name:
GERHARD, JohannAddress:
San Diego, CA 92129, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201562198492 PDate:
29.7.2015Country:
US
Classification
Categories:
C07K 16/28, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 18.6.2021
Expires: 27.7.2022
Payer: Patice ehf.
Number: 7
Paid: 29.6.2022
Expires: 27.7.2023
Payer: Árnason Faktor ehf.
Number: 8
Paid: 28.6.2023
Expires: 27.7.2024
Payer: Árnason Faktor ehf.
Number: 9
Paid: 24.6.2024
Expires: 27.7.2025
Payer: Árnason Faktor ehf.
Number: 10
Paid: 18.7.2025
Expires: 27.7.2026
Payer: Árnason Faktor ehf.